People with diseases caused by rare mutations have fewer options and poorer prospects than other patients despite rapid ...

Shruti Gupta, MD, MPH, and David Leaf, MD, MMSc, of the Renal Division, Department of Medicine at Brigham and Women's ...

UCLA researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug ...

The study, published in Science Translational Medicine, highlights the role of type 5 collagen — a minor component of scar tissue — in kidney fibrosis, and shows how an experimental therapy could help ...

The study, published in Science Translational Medicine, highlights the role of type 5 collagen — a minor component of scar tissue — in kidney fibrosis, and shows how an experimental therapy could help ...

Cysts, fibrosis, and tubular degeneration form the typical triad of pathologies leading to the gradual decline in kidney function in NPHP. Double and/or single deletions of Fbxw7 and Sox9 identified ...

How can advancements in precision medicine and biomarker development improve treatment strategies for pulmonary fibrosis? How do you envision AI impacting management strategies of patients with IPF ...

Groceries cost a kidney, gas a lung. Your 'deals'? Just hot air from your tongue. "Look what you taxed us through! Inflation's ghost chasing me and you. Look what you taxed us through. Rich fly ...

As it advances, excessive fibrosis or buildup of scar tissue impairs the ability of the kidneys to filter toxins from the blood and reabsorb water, often leading to kidney failure. There are ...

The study, published in Science Translational Medicine, highlights the role of type 5 collagen - a minor component of scar tissue - in kidney fibrosis, and shows how an experimental therapy could ...

Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug ...